These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17207879)

  • 61. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
    Prasad CK; Resmi KR; Krishnan LK; Vaishnav R
    J Biomater Appl; 2005 Apr; 19(4):271-86. PubMed ID: 15788425
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
    Togni M; Räber L; Cocchia R; Wenaweser P; Cook S; Windecker S; Meier B; Hess OM
    Int J Cardiol; 2007 Aug; 120(2):212-20. PubMed ID: 17234280
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis, characterization, and paclitaxel release from a biodegradable, elastomeric, poly(ester urethane)urea bearing phosphorylcholine groups for reduced thrombogenicity.
    Hong Y; Ye SH; Pelinescu AL; Wagner WR
    Biomacromolecules; 2012 Nov; 13(11):3686-94. PubMed ID: 23035885
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro and in vivo performance of a dual drug-eluting stent (DDES).
    Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S
    Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Poly(ethylene carbonate)s, part II: degradation mechanisms and parenteral delivery of bioactive agents.
    Stoll GH; Nimmerfall F; Acemoglu M; Bodmer D; Bantle S; Müller I; Mahl A; Kolopp M; Tullberg K
    J Control Release; 2001 Oct; 76(3):209-25. PubMed ID: 11578737
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
    Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fe-Mn alloys for metallic biodegradable stents: degradation and cell viability studies.
    Hermawan H; Purnama A; Dube D; Couet J; Mantovani D
    Acta Biomater; 2010 May; 6(5):1852-60. PubMed ID: 19941977
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Crystalline paclitaxel coated DES with bioactive protective layer development.
    Farah S; Domb AJ
    J Control Release; 2018 Feb; 271():107-117. PubMed ID: 29289571
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vivo biocompatibility and biodegradation of poly(ethylene carbonate).
    Dadsetan M; Christenson EM; Unger F; Ausborn M; Kissel T; Hiltner A; Anderson JM
    J Control Release; 2003 Dec; 93(3):259-70. PubMed ID: 14644576
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modeling and Experimental Studies of Coating Delamination of Biodegradable Magnesium Alloy Cardiovascular Stents.
    Chen C; Tan J; Wu W; Petrini L; Zhang L; Shi Y; Cattarinuzzi E; Pei J; Huang H; Ding W; Yuan G; Migliavacca F
    ACS Biomater Sci Eng; 2018 Nov; 4(11):3864-3873. PubMed ID: 33429615
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Poly 3-Hydroxybutyrate 4-hydroxybutyrate (P34HB) as a Potential Polymer for Drug-Eluting Coatings on Metal Coronary Stents.
    Jian Y; Zhu Y
    Polymers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267817
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dipyridamole-loaded biodegradable PLA nanoplatforms as coatings for cardiovascular stents.
    Bakola V; Karagkiozaki V; Tsiapla AR; Pappa F; Moutsios I; Pavlidou E; Logothetidis S
    Nanotechnology; 2018 Jul; 29(27):275101. PubMed ID: 29629708
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antioxidant-mediated control of degradation and drug release from surface-eroding poly(ethylene carbonate).
    Bohr A; Nascimento TL; Harmankaya N; Antonino RSCMQ; Beck-Broichsitter M
    Acta Biomater; 2020 Sep; 113():210-216. PubMed ID: 32623099
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Studies on a new radiopaque polymeric biomaterial.
    Benzina A; Kruft MA; Bär F; van der Veen FH; Bastiaansen CW; Heijnen V; Reutelingsperger C; Koole LH
    Biomaterials; 1994 Nov; 15(14):1122-8. PubMed ID: 7893914
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of biodegradable zein-based bilayer coatings for drug-eluting stents.
    Lenzuni M; Suarato G; Miele D; Carzino R; Ruggeri M; Bertorelli R; Sandri G; Athanassiou A
    RSC Adv; 2021 Jul; 11(39):24345-24358. PubMed ID: 35479013
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug Release Property of Poly 3-Hydroxybutyrate 4-Hydroxybutyrate (P34HB) as Drug-Eluting Coatings on Metal Coronary Stents.
    Jian Y; Zhu Y
    Polymers (Basel); 2022 Jul; 14(15):. PubMed ID: 35893985
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of a Coated Mitomycin-Releasing Biodegradable Ureteral Stent as an Adjuvant Therapy in Upper Urothelial Carcinoma: A Comparative In Vitro Study.
    Soria F; Aznar-Cervantes SD; de la Cruz JE; Budia A; Aranda J; Caballero JP; Serrano Á; Sánchez Margallo FM
    Polymers (Basel); 2022 Jul; 14(15):. PubMed ID: 35956574
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction.
    Arafat M; Fouladian P; Wignall A; Song Y; Parikh A; Albrecht H; Prestidge CA; Garg S; Blencowe A
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.